CompletedPhase 3NCT02868385
Repeated Doses of Praziquantel in Schistosomiasis Treatment (RePST)
Studying Schistosomiasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Leiden University Medical Center
- Principal Investigator
- Jean CoulibalyCentre Suisse de Recherches Scientifiques en Cote d'Ivoire
- Intervention
- 4x Praziquantel(drug)
- Enrollment
- 167 enrolled
- Eligibility
- 5-18 years · All sexes
- Timeline
- 2018 – 2019
Study locations (1)
- Centre Suisse de Recherches Scientifiques en Côte d'Ivoire, Abidjan, Côte d’Ivoire
Collaborators
Swiss Tropical & Public Health Institute · Centre Suisse de Recherches Scientifiques en Cote d'Ivoire
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02868385 on ClinicalTrials.govOther trials for Schistosomiasis
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06698510Introduction of Arpraziquantel Treatment for Schistosomiasis Control in Preschool-aged Children in Endemic Areas: A Small-scale Public Health Intervention StudyPeter Steinmann
- RECRUITINGNANCT06873308Assessment of Infection Activity in Travelers and Migrants Diagnosed With Chronic SchistosomiasisIRCCS Sacro Cuore Don Calabria di Negrar